• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biol Chem . Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2

tetano

Editor, Senior Moderator
J Biol Chem


. 2021 Aug 31;101151.
doi: 10.1016/j.jbc.2021.101151. Online ahead of print.
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2


Jérémie Prévost[SUP] 1 [/SUP], Jonathan Richard[SUP] 1 [/SUP], Romain Gasser[SUP] 1 [/SUP], Shilei Ding[SUP] 2 [/SUP], Clément Fage[SUP] 3 [/SUP], Sai Priya Anand[SUP] 4 [/SUP], Damien Adam[SUP] 5 [/SUP], Natasha Gupta Vergara[SUP] 6 [/SUP], Alexandra Tauzin[SUP] 1 [/SUP], Mehdi Benlarbi[SUP] 2 [/SUP], Shang Yu Gong[SUP] 4 [/SUP], Guillaume Goyette[SUP] 2 [/SUP], Anik Privé[SUP] 2 [/SUP], Sandrine Moreira[SUP] 7 [/SUP], Hugues Charest[SUP] 7 [/SUP], Michel Roger[SUP] 8 [/SUP], Walther Mothes[SUP] 9 [/SUP], Marzena Pazgier[SUP] 10 [/SUP], Emmanuelle Brochiero[SUP] 5 [/SUP], Guy Boivin[SUP] 3 [/SUP], Cameron F Abrams[SUP] 6 [/SUP], Arne Schön[SUP] 11 [/SUP], Andrés Finzi[SUP] 12 [/SUP]



Affiliations
Free PMC article

Abstract

The seasonal nature of outbreaks of respiratory viral infections with increased transmission during low temperatures has been well established. Accordingly, temperature has been suggested to play a role on the viability and transmissibility of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. The receptor binding domain (RBD) of the Spike glycoprotein is known to bind to its host receptor angiotensin-converting enzyme 2 (ACE2) to initiate viral fusion. Using biochemical, biophysical and functional assays to dissect the effect of temperature on the receptor-Spike interaction, we observed a significant and stepwise increase in RBD-ACE2 affinity at low temperatures, resulting in slower dissociation kinetics. This translated into enhanced interaction of the full Spike glycoprotein with the ACE2 receptor and higher viral attachment at low temperatures. Interestingly, the RBD N501Y mutation, present in emerging variants of concern (VOCs) that are fueling the pandemic worldwide (including the B.1.1.7 (α) lineage), bypassed this requirement. This data suggests that the acquisition of N501Y reflects an adaptation to warmer climates, a hypothesis that remains to be tested.

Keywords: ACE2; COVID-19; Coronavirus; N501Y; RBD; SARS-CoV-2; Spike glycoproteins; neutralization; temperature; variants of concern.
 
Back
Top Bottom